Eckart Matthes

826 citations

43 papers · 701 indexed · h-index 16

Co-authors: Christine Lehmann Martin von Janta‐Lipinski P. Langen Dieter Scholz Wernér E.G. Müller Heinz C. Schröder H. A. Rosenthal Frank F. Bier
Topics: HIV/AIDS drug development and treatment (22 papers)HIV Research and Treatment (18 papers)Hepatitis B Virus Studies (9 papers)
Cited by: Virology Infectious Diseases Hepatology
Journals: Nucleic Acids Research Journal of Biological Chemistry Biochemical and Biophysical Research Communications
Partner nations: Germany Japan Serbia

In The Last Decade

Eckart Matthes

43 papers receiving 669 citations

Peers

Countries citing papers authored by Eckart Matthes

Since Specialization

Citations

This map shows the geographic impact of Eckart Matthes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eckart Matthes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eckart Matthes more than expected).

Fields of papers citing papers by Eckart Matthes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eckart Matthes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eckart Matthes. The network helps show where Eckart Matthes may publish in the future.

Co-authorship network of co-authors of Eckart Matthes

This figure shows the co-authorship network connecting the top 25 collaborators of Eckart Matthes. A scholar is included among the top collaborators of Eckart Matthes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eckart Matthes. Eckart Matthes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Potent Inhibitory Activity of Chimeric Oligonucleotides Targeting Two Different Sites of Human Telomerase 2005 ·Oligonucleotides ·Eckart Matthes,Christine Lehmann,(unknown),Yong Wu,Lora Dimitrova,Eugen Uhlmann,Martin von Janta‐Lipinski	3
2	Real-Time Determination of Telomerase Activity in Cell Extracts Using an Optical Biosensor 2002 ·Biological Chemistry ·Péter Schmidt,Eckart Matthes,(unknown),Michael Bienert,Christine Lehmann,(unknown),Frank F. Bier	22
3	Detection of activity of telomerase in tumor cells using fiber optical biosensors 2002 ·Biosensors and Bioelectronics ·Péter Schmidt,Christine Lehmann,Eckart Matthes,Frank F. Bier	49
4	Inhibition of adenovirus DNA polymerase by modified nucleoside triphosphate analogs correlate with their antiviral effects on cellular level 2000 ·Medical Microbiology and Immunology ·R Mentel,(unknown),Ursula Wegner,Martin von Janta‐Lipinski,Lutz Gürtler,Eckart Matthes	16
5	Telomerase protein rather than its RNA is the target of phosphorothioate-modified oligonucleotides 1999 ·Nucleic Acids Research ·Eckart Matthes	30
6	Chemo-enzymatic synthesis of a new type of enantiomerically pure carbocyclic nucleoside analogues with strong inhibitory effects on terminal deoxynucleotidyl transferase 1998 ·Bioorganic & Medicinal Chemistry ·Fritz Theil,(unknown),(unknown),Martin von Janta‐Lipinski,Eckart Matthes	4
7	Newly Synthesized l-Enantiomers of 3'-Fluoro-Modified β-2'-Deoxyribonucleoside 5'-Triphosphates Inhibit Hepatitis B DNA Polymerases But Not the Five Cellular DNA Polymerases α, β, γ, δ, and ε Nor HIV-1 Reverse Transcriptase 1998 ·Journal of Medicinal Chemistry ·Martin von Janta‐Lipinski,B. Costisella,(unknown),Ulrich Hübscher,Peter Hafkemeyer,Eckart Matthes	22
8	Selective endocytosis of fluorothymidine and azidothymidine coupled to LDL into HIV infected mononuclear cells 1996 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Joachim Mankertz,Eckart Matthes,K. Rokos,Hans von Baeyer,Georg Pauli,Eberhard Riedel	8
9	Tamoxifen is A Na⁺-Antagonistic Inhibitor of Na⁺/K⁺-Transporting ATPase from Tumour and Normal Cells 1994 ·Journal of enzyme inhibition ·K. Repke,Eckart Matthes	6
10	Inhibition of Human Immunodeficiency Virus‐1 Infection by Human Conglutinin‐like Protein: In vitro Studies 1992 ·Japanese Journal of Cancer Research ·Hiroshi Ushijima,Heinz C. Schröder,Slobodan Poznanović,Miroslav J. Gašić,Eckart Matthes,Wernér E.G. Müller	13
11	Human conglutinin-like protein inhibits infection by the human immunodeficiency virus-1 in vitro 1992 ·Research in Virology ·Hiroshi Ushijima,Heinz C. Schröder,(unknown),Eckart Matthes,Wernér E.G. Müller	3
12	Antisense Oligodeoxynucleotide: Inhibitor of Splicing of mRNA of Human Immunodeficiency Virus 1992 ·Intervirology ·(unknown),Joachim W. Engels,(unknown),(unknown),(unknown),Heinz C. Schröder,Eckart Matthes,Wernér E.G. Müller	15
13	Human immunodeficiency virus: novel enzyme-linked immunoassays for quantitation of envelope glycoprotein 120 1991 ·Journal of Virological Methods ·(unknown),Heike Schäcke,Michael Bachmann,Luís Fernando de Macedo Brígido,M. Jean Gilbert,John Mills,Eckart Matthes,(unknown),Wernér E.G. Müller	15
14	Avarol restores the altered prostaglandin and leukotriene metabolism in monocytes infected with human immunodeficiency virus type 1 1991 ·Virus Research ·Heinz C. Schröder,M.E. Bégin,R. Klöcking,Eckart Matthes,(unknown),Miroslav J. Gašić,Wernér E.G. Müller	25
15	Alteration of DNA topoisomerase II activity during infection of H9 cells by human immunodeficiency virus type 1 in vitro: A target for potential therapeutic agents 1990 ·Antiviral Research ·Eckart Matthes,P. Langen,H. Brachwitz,Heinz C. Schröder,Armin Maidhof,(unknown),(unknown),Wernér E.G. Müller	18
16	Effects of suramin, HPA-23 and 3'-azidothymidine triphosphate on the reverse transcriptase of bovine leukaemia virus. 1989 ·PubMed ·(unknown),Eckart Matthes,Dieter Scholz,H. A. Rosenthal	4
17	The Antiretroviral and Cytostatic Activity, and Metabolism of 3′-Azido-2′, 3′-Dideoxythymidine, 3′-Fluoro-2′, 3′-Dideoxythymidine and 2′, 3′-Dideoxycytidine are Highly Cell Type-Dependent 1989 ·Advances in experimental medicine and biology ·Jan Balzarini,Eckart Matthes,Pierre Méeus,David G. Johns,Erik De Clercq	5
18	Phosphorylation, anti-HIV activity and cytotoxicity of 3′-fluorothymidine 1988 ·Biochemical and Biophysical Research Communications ·Eckart Matthes,Christine Lehmann,Dieter Scholz,H. A. Rosenthal,P. Langen	76
19	Inhibition of HIV-associated reverse transcriptase by sugar-modified derivatives of thymidine 5′-triphosphate in comparison to cellular DNA polymerases α and β 1987 ·Biochemical and Biophysical Research Communications ·Eckart Matthes,Christine Lehmann,Dieter Scholz,Martin von Janta‐Lipinski,(unknown),H. A. Rosenthal,P. Langen	88
20	Inhibition by 6-aminothymine of the degradation of nucleosides (5-iododeoxyuridine, thymidine) and pyrimidine bases (5-iodouracil, uracil and 5-fluorouracil) in vivo. 1974 ·PubMed ·Eckart Matthes,(unknown),P. Langen	6

About Eckart Matthes

Eckart Matthes is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 43 papers that have together received 701 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (22 papers), HIV Research and Treatment (18 papers) and Hepatitis B Virus Studies (9 papers). The work is most often cited by research in Virology (224 citations), Infectious Diseases (297 citations) and Hepatology (59 citations). Eckart Matthes has collaborated with scholars based in Germany, Japan and Serbia. Frequent co-authors include Christine Lehmann, Martin von Janta‐Lipinski, P. Langen, Dieter Scholz, Wernér E.G. Müller, Heinz C. Schröder, H. A. Rosenthal, Frank F. Bier, Péter Schmidt and Lee Leserman. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact